FDA Approves New Implanted Hearing Device

Article

The Food and Drug Administration (FDA) has approved a new type of surgically implanted hearing device intended to help adults with moderate to severe nerve hearing loss. The device, the first of its kind, is an alternative to traditional hearing aids. Made by Symphonix Inc., of San Jose, Calif., the device is implanted behind the ear in the temporal bone. It takes sound and converts it to mechanical energy that is directly transferred to the middle ear. The energy vibrates in the middle ear, a process similar to normal sound. For more information visit www.fda.gov.

Recent Videos
Pathogen Playbook Presenter: Sharon Ward-Fore, BS, MS, MT(ASCP), CIC, FAPIC
Mark Wiencek, PhD
Rebecca Crapanzano-Sigafoos, DrPH, CIC, AL-CIP, FAPIC
The CDC’s updated hospital respiratory reporting requirement has added new layers of responsibility for infection preventionists. Karen Jones, MPH, RN, CIC, FAPIC, clinical program manager at Wolters Kluwer, breaks down what it means and how IPs can adapt.
Studying for the CIC using a digital tablet and computer (Adobe Stock 335828989 by NIKCOA)
Infection Control Today's Conversations with the HSPA President, Arlene Bush, CRCST, CER, CIS, SME, DSMD, CRMST
Infection Control Today's Conversations with the HSPA President, Arlene Bush, CRCST, CER, CIS, SME, DSMD, CRMST
Cheron Rojo, BS, FCS, CHL,  CER, CFER, CRCST
Matthias Tschoerner, Dr Sc
Standardizing Cleaning and Disinfection
Related Content